New vaccine is cheap for Africa

Europe's largest pharmaceutical company GSK has announced the production of cheap vaccines for African countries: Globorix vaccine helps prevent meningitis.

Children are particularly at risk of meningitis (Photo: AFP)

The price of this vaccine may not be enough to cover research costs: over $ 400 million, and only sold and used in Africa alone.

Globorix aims to prevent meningitis A and C with more efficacy than the old vaccine called Titanrix, which helps prevent diphtheria, tetanus, coughing on the day, Haemophilus influenzae - the culprit causing meningitis.

According to experts, this is a sign that big companies are changing business habits, but some commentators think that is not enough. The GSK said that this action is not a " way " of their new business, nor a form of PR.

Millions of people in Africa are at high risk of meningitis, which can kill a child within 6 hours.

T.VY